US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALX Oncology Holdings

0.5303

-0.0114-2.10%

Post-market: 0.5023-0.0280-5.28%19:08 EDT

Volume:427.90K

Turnover:226.95K

Market Cap:28.31M

PE:-0.21

High:0.5642

Open:0.5200

Low:0.5115

Close:0.5417

Loading ...

Overview Company News Filings

LifeSci Capital Reaffirms Their Hold Rating on ALX Oncology Holdings (ALXO)

ALX Oncology Phase 1/2 Evorpacept Trial to Treat B-cell Non-Hodgkin Lymphoma Shows Anti-tumor Activity

MT Newswires Live

ALX Oncology reports ‘encouraging’ final results from Phase 1 evorpacept trial

ALX Oncology Announces Encouraging Final Results From Phase 1 Trial Evaluating Evorpacept in Combination With Standard-of-Care Treatment in Patients With B-Cell Non-Hodgkin Lymphoma

THOMSON REUTERS

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

ALX Oncology's Phase 2 Trials of Evorpacept, Keytruda Combination in Head, Neck Cancers Fail to Meet Primary Endpoints

MT Newswires Live

ALX Oncology Reports Aspen-03 and Aspen-04 Phase 2 Trials Evaluating Evorpacept With a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints

THOMSON REUTERS

ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints

BRIEF-Alx Oncology Receives Ind Clearance From U.S. FDA For Alx2004

ALX Oncology receives IND clearance from FDA for ALX2004

ALX Oncology Holdings Inc - to Start Phase 1 Trial for Alx2004 in Mid-2025

THOMSON REUTERS

ALX Oncology Receives Ind Clearance From U.S. FDA for Alx2004, a Novel Egfr-Targeted Antibody-Drug Conjugate

THOMSON REUTERS

ALX Oncology Holdings: Balancing Growth Potential and Uncertainty with a Hold Rating

Why ALX Oncology Holdings Inc. (ALXO) Soared on Thursday

ALX Oncology Is Maintained at Hold by Stifel

ALX Oncology Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

BRIEF-Alx Oncology Holdings Inc Files For Mixed Shelf Of Up To $364.1 Million

ALX Oncology files $364.12M mixed securities shelf

ALX Oncology Holdings Inc Files for Mixed Shelf of up to $364.1 Mln - SEC Filing

THOMSON REUTERS

ALX Oncology to Cut 30% of Workforce, Names New CFO

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALXO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALXO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALXO\",,,,,undefined,":{"symbol":"ALXO","market":"US","secType":"STK","nameCN":"ALX Oncology Holdings","latestPrice":0.5303,"timestamp":1745870400000,"preClose":0.5417,"halted":0,"volume":427897,"hourTrading":{"tag":"盘后","latestPrice":0.5023,"preClose":0.5303,"latestTime":"19:08 EDT","volume":456,"amount":241.46162159999997,"timestamp":1745881700762},"delay":0,"floatShares":32339116,"shares":53384145,"eps":-2.584575,"marketStatus":"Post-Mkt","change":-0.0114,"latestTime":"04-28 19:59:48 EDT","open":0.52,"high":0.5642,"low":0.5115,"amount":226946.53461534998,"amplitude":0.097286,"askPrice":0.54,"askSize":1500,"bidPrice":0.4573,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-2.584575,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745884800000},"marketStatusCode":4,"adr":0,"listingDate":1594958400000,"exchange":"NASDAQ","adjPreClose":0.5417,"preHourTrading":{"tag":"盘前","latestPrice":0.5471,"preClose":0.5417,"latestTime":"09:17 EDT","volume":3065,"amount":1683.4687205,"timestamp":1745846222470},"postHourTrading":{"tag":"盘后","latestPrice":0.5023,"preClose":0.5303,"latestTime":"19:08 EDT","volume":456,"amount":241.46162159999997,"timestamp":1745881700762},"volumeRatio":0.710684,"impliedVol":1.5858,"impliedVolPercentile":0.632},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALXO\",,,,,undefined,":{"symbol":"ALXO","floatShares":32339116,"roa":"-45.62%","roe":"-88.91%","lyrEps":-2.584575,"volumeRatio":0.710684,"shares":53384145,"dividePrice":0,"high":0.5642,"amplitude":0.097286,"preClose":0.5417,"low":0.5115,"week52Low":0.46,"pbRate":"0.25","week52High":17.825,"institutionHeld":0,"latestPrice":0.5303,"committee":-0.875,"eps":-2.584575,"divideRate":0,"volume":427897,"delay":0,"ttmEps":-2.584575,"open":0.52,"prevYearClose":1.67,"prevWeekClose":0.5417,"prevMonthClose":0.623,"prevQuarterClose":0.623,"fiveDayClose":0.5662,"twentyDayClose":0.6551,"sixtyDayClose":1.305},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALXO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530034285","title":"LifeSci Capital Reaffirms Their Hold Rating on ALX Oncology Holdings (ALXO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530034285","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530034285?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:35","pubTimestamp":1745847355,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky maintained a Hold rating on ALX Oncology Holdings (ALXO – Research Report) today. The company’s shares opened t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-reaffirms-their-hold-rating-on-alx-oncology-holdings-alxo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-reaffirms-their-hold-rating-on-alx-oncology-holdings-alxo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALXO","ALX"],"gpt_icon":0},{"id":"2530163491","title":"ALX Oncology Phase 1/2 Evorpacept Trial to Treat B-cell Non-Hodgkin Lymphoma Shows Anti-tumor Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2530163491","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530163491?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:44","pubTimestamp":1745603098,"startTime":"0","endTime":"0","summary":"ALX Oncology  said Friday that data from its ongoing phase 1/2 trial of its evorpacept investigational drug in combination with rituximab and lenalidomide in patients with indolent and aggressive relapsed or refractory B-cell non-Hodgkin lymphoma showed anti-tumor activity.A median follow-up of 28 months on the patients revealed that the two-year progression-free survival rate was 69% and the two-year overall survival rate was 84%, while 80% achieved complete responses, the company said.The complete response rate was higher than that of patients who received the standard-of-care rituximab and lenalidomide treatment, the company said.The phase 2 portion of the study in patients with previously untreated indolent non-Hodgkin lymphoma is ongoing and has completed enrollment, the company added.Shares of the company were down 9.3% in recent Friday trading.Price: 0.55, Change: -0.06, Percent Change: -9.32","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","ALXO","ALX","BK4080","BK4139"],"gpt_icon":0},{"id":"2530150074","title":"ALX Oncology reports ‘encouraging’ final results from Phase 1 evorpacept trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2530150074","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530150074?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:15","pubTimestamp":1745601358,"startTime":"0","endTime":"0","summary":"ALX Oncology (ALXO) announced “encouraging” data from an ongoing Phase 1/2 investigator-sponsored trial of the company’s lead clinical candidate, e...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alx-oncology-reports-encouraging-final-results-from-phase-1-evorpacept-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alx-oncology-reports-encouraging-final-results-from-phase-1-evorpacept-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALXO","BK4139","BK4231","ALX","BK4080"],"gpt_icon":0},{"id":"2530501851","title":"ALX Oncology Announces Encouraging Final Results From Phase 1 Trial Evaluating Evorpacept in Combination With Standard-of-Care Treatment in Patients With B-Cell Non-Hodgkin Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2530501851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530501851?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:10","pubTimestamp":1745601000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nTUABTG6CN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2530685901","title":"ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2530685901","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530685901?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:10","pubTimestamp":1745601000,"startTime":"0","endTime":"0","summary":"- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus rituximab and lenalidomide  was well-tolerated and demonstrated promising anti-tumor activity. - Combination generated complete responses  in 83% of patients with indolent relapsed or refractory B-cell non-Hodgkin lymphoma  comparing favorably to 34% historical CR rate with R2 alone. - Phase 2 portion of trial in patients with previously untreated indolent NHL  is ongoing and has completed enrollment. After a median follow-up of 28 months  the two-year progression-free survival  rate was 69% and two-year overall survival  rate was 84%. Sixteen patients (80%) achieved complete responses and the best overall response rate  was 90%. As previously repo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alx-oncology-announces-encouraging-final-171000715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4124","BK4211","BK4139","CR","ALXO","SMP","ORR","PFS","BK4231","ALX","BK4161","BK4195","OS","BK4097","BK4080"],"gpt_icon":0},{"id":"2530131735","title":"ALX Oncology's Phase 2 Trials of Evorpacept, Keytruda Combination in Head, Neck Cancers Fail to Meet Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2530131735","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530131735?lang=en_us&edition=fundamental","pubTime":"2025-04-25 21:52","pubTimestamp":1745589120,"startTime":"0","endTime":"0","summary":"ALX Oncology  said Friday that two phase 2 trials evaluating evorpacept in combination with Merck's  Keytruda in patients with advanced head and neck squamous cell carcinoma failed to meet their primary endpoints of improved objective response rates.The company said efficacy data from the trials do not support advancing the combination into a registrational study and it will no longer pursue the combination therapy in advanced head and neck squamous cell carcinoma.ALX said, however, that several trials of evorpacept in combination with other anti-cancer antibodies will continue based on established proof-of-concept.ALX Oncology shares were down more than 4% in recent Friday trading.Price: 0.58, Change: -0.02, Percent Change: -3.49","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0965508806.USD","LU0289739699.SGD","LU1093756325.SGD","LU1069347547.HKD","LU1116320737.USD","LU2089984988.USD","BK4139","LU1066053197.SGD","LU1941712264.USD","LU1430594728.SGD","LU1941712348.USD","LU1023059063.AUD","LU0006306889.USD","IE00BSNM7G36.USD","LU1066051225.USD","LU1291159041.SGD","BK4533","LU1989771016.USD","BK4231","ALXO","IE0009355771.USD","MRK","BK4516","SG9999001176.SGD","LU1585245621.USD","SG9999015341.SGD","BK4585","LU0203347892.USD","LU0266013472.USD","LU0965509010.AUD","LU2023250843.SGD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU0965509283.SGD","LU1037948541.HKD","LU2112291526.USD","LU0985320562.USD","LU1093756168.USD","SGXZ57979304.SGD","LU0965509101.SGD","LU2023250504.SGD","IE00BLSP4239.USD","IE0002141913.USD","LU2324357040.USD","IE00B1BXHZ80.USD","LU0058720904.USD","LU2468319806.SGD","ALX","LU0070302665.USD","SG9999014559.SGD"],"gpt_icon":0},{"id":"2530133316","title":"ALX Oncology Reports Aspen-03 and Aspen-04 Phase 2 Trials Evaluating Evorpacept With a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2530133316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530133316?lang=en_us&edition=fundamental","pubTime":"2025-04-25 21:00","pubTimestamp":1745586002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nTUA7TX2KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2530513653","title":"ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2530513653","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530513653?lang=en_us&edition=fundamental","pubTime":"2025-04-25 21:00","pubTimestamp":1745586000,"startTime":"0","endTime":"0","summary":"In ASPEN-03 and ASPEN-04 trials, efficacy data do not support advancing evorpacept in combination with Merck’s anti-PD-1 therapy, KEYTRUDA , into a registrational study. Company remains confident in continuing to pursue evorpacept in multiple clinical trials, based on the different mechanism of evorpacept in combination with anti-cancer antibodies, as evidenced by durable clinical response and consistent safety data in prior clinical trials. In the ASPEN-03 and ASPEN-04 clinical trials, evorpacept was combined with pembrolizumab with or without chemotherapy to investigate a second and distinct mechanism of action. This discrete approach explored the concept that evorpacept may enhance T-cell priming by activating dendritic cells and stimulating the adaptive immune system. The trial outcomes were not sufficiently supportive of advancing evorpacept in combination with pe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alx-oncology-reports-aspen-03-130000813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0861579265.USD","ALX","LU2106854487.HKD","LU1035773651.USD","PFS","LU2089984988.USD","LU0234572021.USD","SG9999001176.USD","BK4550","ALXO","LU1116320737.USD","LU1066051811.HKD","IE000M9KFDE8.USD","LU0203345920.USD","SG9999014559.SGD","LU0265550946.USD","LU0211331839.USD","LU1037948541.HKD","LU1974910355.USD","LU0965508806.USD","LU1934455277.USD","LU1093756325.SGD","LU1983299246.USD","LU1116320901.HKD","LU2461242641.AUD","LU1291159041.SGD","IE00B2B36J28.USD","LU1934455863.HKD","LU1057294990.SGD","LU1989772840.SGD","BK4097","SG9999014567.USD","IE00B1BXHZ80.USD","LU1069347547.HKD","IE00BN8TJ469.HKD","LU1917777945.USD","BK4516","ORR","OS","MRK","LU0965509283.SGD","LU1037948897.HKD","LU1941712264.USD","SG9999014542.SGD","LU2468319806.SGD","LU1934455194.USD","IE0002141913.USD","BK4231","IE00BFTCPJ56.SGD","BK4080"],"gpt_icon":0},{"id":"2525048409","title":"BRIEF-Alx Oncology Receives Ind Clearance From U.S. FDA For Alx2004","url":"https://stock-news.laohu8.com/highlight/detail?id=2525048409","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525048409?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:53","pubTimestamp":1744030400,"startTime":"0","endTime":"0","summary":"BRIEF-Alx Oncology Receives Ind Clearance From U.S. FDA For Alx2004April 7 (Reuters) - ALX Oncology Holdings Inc ALXO.O:ALX ONCOLOGY RECEIVES IND CLEARANCE FROM U.S. FDA FOR ALX2004,  A NOVEL EGFR-TAR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUA91DMK1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2525048947","title":"ALX Oncology receives IND clearance from FDA for ALX2004","url":"https://stock-news.laohu8.com/highlight/detail?id=2525048947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525048947?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:30","pubTimestamp":1744029040,"startTime":"0","endTime":"0","summary":"ALX Oncology (ALXO) announced receipt of U.S. Food and Drug Administration clearance for the Investigational New Drug application for ALX2004, the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alx-oncology-receives-ind-clearance-from-fda-for-alx2004?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alx-oncology-receives-ind-clearance-from-fda-for-alx2004?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALXO","ALX","BK4080","BK4231"],"gpt_icon":0},{"id":"2525120650","title":"ALX Oncology Holdings Inc - to Start Phase 1 Trial for Alx2004 in Mid-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525120650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525120650?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUA91DMK1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2525012080","title":"ALX Oncology Receives Ind Clearance From U.S. FDA for Alx2004,  a Novel Egfr-Targeted Antibody-Drug Conjugate","url":"https://stock-news.laohu8.com/highlight/detail?id=2525012080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525012080?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUA91DMK1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2518224778","title":"ALX Oncology Holdings: Balancing Growth Potential and Uncertainty with a Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224778","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518224778?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:35","pubTimestamp":1741613737,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky has maintained their neutral stance on ALXO stock, giving a Hold rating on March 7. Sam Slutsky has given his H...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/alx-oncology-holdings-balancing-growth-potential-and-uncertainty-with-a-hold-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/alx-oncology-holdings-balancing-growth-potential-and-uncertainty-with-a-hold-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALX","ALXO"],"gpt_icon":0},{"id":"2517204468","title":"Why ALX Oncology Holdings Inc. (ALXO) Soared on Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2517204468","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517204468?lang=en_us&edition=fundamental","pubTime":"2025-03-08 02:27","pubTimestamp":1741372034,"startTime":"0","endTime":"0","summary":"The stock market pulled back to the red territory on Thursday, with all major indices posting significant losses as tariff threats continued to rattle investors.The tech-heavy Nasdaq posted the largest loss, down 2.61 percent, followed by the S&P 500 with 1.78 percent, and the Dow Jones with 0.99 percent.On Thursday, 10 micro and small-cap companies defied a broader market decline, with their share prices jumping by as much as double digits. One company stood out, soaring more than 300 percent during the session.ALX Oncology Holdings Inc.  saw its share prices increase by 25.96 percent to finish at $1.31 apiece as investors cheered news of better earnings performance in the fourth quarter and full year of 2024.In a statement, ALX Oncology Holdings Inc.  said net loss in the fourth quarter narrowed by 36 percent to $29.16 million from $45.47 million in the same period a year earlier, while net loss in the full year shrunk by 16 percent to $134.85 million from $160.8 million.Looking ahea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-alx-oncology-holdings-inc-182714950.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","NQmain","NVIW.SI","ALX","BK4231","SQQQ","BK4080","USAW.SI","ALXO","TSYW.SI","BK4139","TQQQ","QID","QLD","MNQmain",".IXIC","USJW.SI"],"gpt_icon":1},{"id":"2517645378","title":"ALX Oncology Is Maintained at Hold by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2517645378","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517645378?lang=en_us&edition=fundamental","pubTime":"2025-03-08 00:50","pubTimestamp":1741366200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALXO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 07, 2025 11:50 ET (16:50 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SF","ALXO","BK4231","BK4080","ALX","BK4127"],"gpt_icon":0},{"id":"2517671480","title":"ALX Oncology Price Target Maintained With a $5.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2517671480","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517671480?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:16","pubTimestamp":1741349760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALXO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 07, 2025 07:16 ET (12:16 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALXO","ALX"],"gpt_icon":0},{"id":"2517111379","title":"BRIEF-Alx Oncology Holdings Inc Files For Mixed Shelf Of Up To $364.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517111379","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517111379?lang=en_us&edition=fundamental","pubTime":"2025-03-07 06:35","pubTimestamp":1741300545,"startTime":"0","endTime":"0","summary":"BRIEF-Alx Oncology Holdings Inc Files For Mixed Shelf Of Up To $364.1 MillionMarch 6 (Reuters) - ALX Oncology Holdings Inc ALXO.O:ALX ONCOLOGY HOLDINGS INC FILES FOR MIXED SHELF OF UP TO $364.1 MILLION - SEC FILINGFurther company coverage: ALXO.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP1N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2517600114","title":"ALX Oncology files $364.12M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600114","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517600114?lang=en_us&edition=fundamental","pubTime":"2025-03-07 06:30","pubTimestamp":1741300230,"startTime":"0","endTime":"0","summary":"17:27 EST ALX Oncology (ALXO) files $364.12M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alx-oncology-files-364-12m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alx-oncology-files-364-12m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","BK4080","BK4139","ALXO","ALX"],"gpt_icon":0},{"id":"2517119797","title":"ALX Oncology Holdings Inc Files for Mixed Shelf of up to $364.1 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2517119797","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517119797?lang=en_us&edition=fundamental","pubTime":"2025-03-07 06:27","pubTimestamp":1741300034,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP1N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2517111064","title":"ALX Oncology to Cut 30% of Workforce, Names New CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2517111064","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517111064?lang=en_us&edition=fundamental","pubTime":"2025-03-07 06:07","pubTimestamp":1741298820,"startTime":"0","endTime":"0","summary":"ALX Oncology is cutting about 30% of its workforce and realigning its focus.The clinical-stage biotechnology company named Harish Shantharam as chief financial officer and Alan Sandler as chief medical officer.ALX said its \"strategic prioritization and resource optimization\" plan, which primarily will affect its preclinical research department, is expected to extend its cash runway into the fourth quarter of 2026. As of Dec. 31, ALX had cash, cash equivalents and investments of $131.3 million.The company expects results from several Phase 2 trials related to head and neck squamous cell carcinoma in the second quarter.ALX said its loss for the three months ended Dec. 31 was 55 cents a share, compared with a loss of 93 cents in the year-earlier period, due to lower research and development expenses.ALX also named Barbara Klencke and Chris Takimoto to its board of directors.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALX","ALXO","BK4080","BK4231","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":70,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALXO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-06","symbol":"ALXO","fiscalQuarterEnding":"2024/12","expectedEps":-0.68,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.55},{"market":"US","date":"2024-11-07","symbol":"ALXO","fiscalQuarterEnding":"2024/09","expectedEps":-0.78,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2024-08-08","symbol":"ALXO","fiscalQuarterEnding":"2024/06","expectedEps":-0.77,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.76},{"market":"US","date":"2024-05-09","symbol":"ALXO","fiscalQuarterEnding":"2024/03","expectedEps":-0.87,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2024-03-07","symbol":"ALXO","fiscalQuarterEnding":"2023/12","expectedEps":-0.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709787600000,"reportTimeType":"post","actualEps":-0.93}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALXO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALXO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.6667,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1741492800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALXO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALXO","date":"2025-04-25","current":-0.237923,"percent":0.987234,"low":-127.638043,"twenty":-48.209827,"median":-4.430186,"eighty":-1.611596,"high":-0.190021,"avg":-20.084002,"sd":28.030975,"marketCap":32083871},"quantilePoints":[{"date":"2020-07-17","current":-51.632367,"twenty":-44.059627,"median":-32.700517,"eighty":-27.964215,"marketCap":1056346590},{"date":"2020-07-24","current":-53.947809,"twenty":-53.555461,"median":-52.280454,"eighty":-40.273257,"marketCap":1103718228},{"date":"2020-07-31","current":-58.317136,"twenty":-57.311299,"median":-53.32362,"eighty":-51.859549,"marketCap":1193110283},{"date":"2020-08-07","current":-78.808386,"twenty":-66.642041,"median":-55.659872,"eighty":-52.264427,"marketCap":1612340777},{"date":"2020-08-14","current":-81.037635,"twenty":-77.25683,"median":-58.138796,"eighty":-52.603126,"marketCap":1657948968},{"date":"2020-08-21","current":-80.377777,"twenty":-78.451707,"median":-66.360264,"eighty":-53.109612,"marketCap":1644448943},{"date":"2020-08-28","current":-59.283293,"twenty":-78.408905,"median":-67.769149,"eighty":-53.573296,"marketCap":1635803910},{"date":"2020-09-04","current":-57.595227,"twenty":-78.255533,"median":-59.223005,"eighty":-54.040246,"marketCap":1589225086},{"date":"2020-09-11","current":-52.825768,"twenty":-77.995157,"median":-58.89477,"eighty":-53.969912,"marketCap":1457621427},{"date":"2020-09-18","current":-50.052516,"twenty":-77.72408,"median":-58.138796,"eighty":-52.854002,"marketCap":1381099075},{"date":"2020-09-25","current":-52.343464,"twenty":-77.370967,"median":-57.307184,"eighty":-52.397352,"marketCap":1444313192},{"date":"2020-10-02","current":-46.395038,"twenty":-77.292498,"median":-55.933955,"eighty":-52.226272,"marketCap":1280178291},{"date":"2020-10-09","current":-47.774966,"twenty":-77.014288,"median":-54.527039,"eighty":-50.69023,"marketCap":1318254631},{"date":"2020-10-16","current":-57.742597,"twenty":-76.461434,"median":-54.058325,"eighty":-50.071272,"marketCap":1593291492},{"date":"2020-10-23","current":-55.947352,"twenty":-75.765908,"median":-54.902164,"eighty":-50.229361,"marketCap":1543755283},{"date":"2020-10-30","current":-52.932947,"twenty":-72.07784,"median":-54.674603,"eighty":-50.69023,"marketCap":1460578813},{"date":"2020-11-06","current":-61.62783,"twenty":-67.205595,"median":-54.902164,"eighty":-51.215407,"marketCap":1700496720},{"date":"2020-11-13","current":-54.256262,"twenty":-65.197086,"median":-55.356773,"eighty":-51.333096,"marketCap":1884319967},{"date":"2020-11-20","current":-79.001733,"twenty":-69.838643,"median":-55.779885,"eighty":-51.745958,"marketCap":2743730176},{"date":"2020-11-27","current":-73.20001,"twenty":-73.20001,"median":-55.940653,"eighty":-52.200323,"marketCap":2542236332},{"date":"2020-12-04","current":-78.232443,"twenty":-77.149826,"median":-56.444567,"eighty":-52.330066,"marketCap":2717012760},{"date":"2020-12-11","current":-91.41367,"twenty":-77.809683,"median":-57.106223,"eighty":-52.343464,"marketCap":3174796768},{"date":"2020-12-18","current":-95.406578,"twenty":-78.398205,"median":-57.742597,"eighty":-52.360584,"marketCap":3313470449},{"date":"2020-12-24","current":-101.693591,"twenty":-78.672443,"median":-57.88912,"eighty":-52.379042,"marketCap":3531818430},{"date":"2020-12-31","current":-98.894264,"twenty":-79.717412,"median":-58.317136,"eighty":-52.480117,"marketCap":3434597796},{"date":"2021-01-08","current":-98.664811,"twenty":-81.501149,"median":-58.89477,"eighty":-52.560501,"marketCap":3426628892},{"date":"2021-01-15","current":-95.601613,"twenty":-87.560076,"median":-59.283293,"eighty":-52.611411,"marketCap":3320244018},{"date":"2021-01-22","current":-93.4677,"twenty":-92.198654,"median":-61.62783,"eighty":-52.71323,"marketCap":3246133207},{"date":"2021-01-29","current":-90.920771,"twenty":-92.818347,"median":-64.414983,"eighty":-52.86864,"marketCap":3157678368},{"date":"2021-02-05","current":-91.918892,"twenty":-92.818347,"median":-67.769149,"eighty":-52.946544,"marketCap":3192343102},{"date":"2021-02-12","current":-93.811879,"twenty":-92.93078,"median":-71.292813,"eighty":-53.076598,"marketCap":3258086563},{"date":"2021-02-19","current":-100.443072,"twenty":-93.460816,"median":-73.177512,"eighty":-53.251804,"marketCap":3488387901},{"date":"2021-02-26","current":-92.113927,"twenty":-93.460816,"median":-75.475824,"eighty":-53.300465,"marketCap":3199116671},{"date":"2021-03-05","current":-78.725341,"twenty":-93.759105,"median":-76.81098,"eighty":-53.358023,"marketCap":2734131099},{"date":"2021-03-12","current":-88.511514,"twenty":-93.531946,"median":-77.381667,"eighty":-53.551905,"marketCap":3074004872},{"date":"2021-03-19","current":-55.330616,"twenty":-93.460816,"median":-77.595675,"eighty":-53.798417,"marketCap":2530822377},{"date":"2021-03-26","current":-57.725615,"twenty":-93.382802,"median":-77.149826,"eighty":-53.896889,"marketCap":2640369628},{"date":"2021-04-01","current":-65.077297,"twenty":-93.180883,"median":-76.418632,"eighty":-53.947809,"marketCap":2976635547},{"date":"2021-04-09","current":-55.944718,"twenty":-92.985848,"median":-74.108199,"eighty":-54.058325,"marketCap":2558911416},{"date":"2021-04-16","current":-53.27776,"twenty":-92.939958,"median":-72.516197,"eighty":-53.495636,"marketCap":2436924734},{"date":"2021-04-23","current":-55.155158,"twenty":-92.917012,"median":-68.342322,"eighty":-53.294676,"marketCap":2522796938},{"date":"2021-04-30","current":-55.111578,"twenty":-92.882594,"median":-65.454531,"eighty":-53.32362,"marketCap":2520803591},{"date":"2021-05-07","current":-57.152096,"twenty":-92.848176,"median":-65.014338,"eighty":-53.495636,"marketCap":2614136887},{"date":"2021-05-14","current":-48.726164,"twenty":-92.721977,"median":-63.919275,"eighty":-53.294676,"marketCap":2228734742},{"date":"2021-05-21","current":-40.258673,"twenty":-92.653141,"median":-63.17505,"eighty":-52.94439,"marketCap":2192930159},{"date":"2021-05-28","current":-41.772712,"twenty":-92.263071,"median":-61.62783,"eighty":-52.571219,"marketCap":2275401390},{"date":"2021-06-04","current":-40.517167,"twenty":-92.143756,"median":-60.822445,"eighty":-52.379042,"marketCap":2207010613},{"date":"2021-06-11","current":-44.062235,"twenty":-91.957899,"median":-60.25961,"eighty":-52.086732,"marketCap":2400113984},{"date":"2021-06-18","current":-43.788969,"twenty":-91.78122,"median":-59.283293,"eighty":-50.873988,"marketCap":2385228933},{"date":"2021-06-25","current":-42.27493,"twenty":-91.480296,"median":-59.109127,"eighty":-50.078046,"marketCap":2302757701},{"date":"2021-07-02","current":-41.285265,"twenty":-91.377297,"median":-58.667015,"eighty":-49.378663,"marketCap":2248849677},{"date":"2021-07-09","current":-41.706242,"twenty":-91.34067,"median":-58.164259,"eighty":-48.538615,"marketCap":2271780702},{"date":"2021-07-16","current":-40.251287,"twenty":-91.104251,"median":-57.987212,"eighty":-47.965726,"marketCap":2192527860},{"date":"2021-07-23","current":-44.305958,"twenty":-90.936013,"median":-57.742597,"eighty":-46.338892,"marketCap":2413389841},{"date":"2021-07-30","current":-43.249823,"twenty":-90.466454,"median":-57.394267,"eighty":-44.85692,"marketCap":2355861128},{"date":"2021-08-06","current":-49.113956,"twenty":-89.509635,"median":-57.10274,"eighty":-45.119846,"marketCap":2675286288},{"date":"2021-08-13","current":-45.262916,"twenty":-88.805214,"median":-56.707355,"eighty":-45.130443,"marketCap":2689250914},{"date":"2021-08-20","current":-42.492549,"twenty":-88.557404,"median":-55.947352,"eighty":-44.982206,"marketCap":2524652298},{"date":"2021-08-27","current":-50.973404,"twenty":-88.256821,"median":-55.900461,"eighty":-45.082566,"marketCap":3028533845},{"date":"2021-09-03","current":-48.868468,"twenty":-88.066375,"median":-55.679405,"eighty":-45.130443,"marketCap":2903471172},{"date":"2021-09-10","current":-52.759205,"twenty":-88.038841,"median":-55.330616,"eighty":-45.198345,"marketCap":3134635404},{"date":"2021-09-17","current":-52.833896,"twenty":-87.975981,"median":-55.194935,"eighty":-45.273044,"marketCap":3139073112},{"date":"2021-09-24","current":-50.912293,"twenty":-87.775903,"median":-55.111578,"eighty":-45.344367,"marketCap":3024902994},{"date":"2021-10-01","current":-50.518467,"twenty":-87.47246,"median":-54.984083,"eighty":-45.527983,"marketCap":3001504171},{"date":"2021-10-08","current":-41.548723,"twenty":-87.079132,"median":-54.929153,"eighty":-45.344367,"marketCap":2468575809},{"date":"2021-10-15","current":-40.054897,"twenty":-86.164209,"median":-54.475312,"eighty":-45.077267,"marketCap":2379821654},{"date":"2021-10-22","current":-36.70058,"twenty":-84.954992,"median":-54.178901,"eighty":-44.359134,"marketCap":2180528231},{"date":"2021-10-29","current":-38.051813,"twenty":-84.221162,"median":-53.915984,"eighty":-43.969177,"marketCap":2260810399},{"date":"2021-11-05","current":-34.602434,"twenty":-83.375712,"median":-53.495636,"eighty":-43.582173,"marketCap":2055868986},{"date":"2021-11-12","current":-25.205542,"twenty":-82.343867,"median":-53.311679,"eighty":-43.170059,"marketCap":1860143780},{"date":"2021-11-19","current":-21.001874,"twenty":-81.732906,"median":-53.27776,"eighty":-42.526625,"marketCap":1549917319},{"date":"2021-11-26","current":-18.433576,"twenty":-80.942444,"median":-53.091921,"eighty":-42.023386,"marketCap":1360379481},{"date":"2021-12-03","current":-16.106742,"twenty":-80.524899,"median":-52.985295,"eighty":-41.694425,"marketCap":1188661440},{"date":"2021-12-10","current":-17.056134,"twenty":-80.373956,"median":-52.932947,"eighty":-41.567457,"marketCap":1258725641},{"date":"2021-12-17","current":-13.110394,"twenty":-80.254576,"median":-52.792486,"eighty":-41.255723,"marketCap":967533962},{"date":"2021-12-23","current":-12.764661,"twenty":-79.838188,"median":-52.604712,"eighty":-40.856903,"marketCap":942019253},{"date":"2021-12-31","current":-11.793318,"twenty":-79.289904,"median":-52.535131,"eighty":-40.627951,"marketCap":870335071},{"date":"2022-01-07","current":-10.53112,"twenty":-79.001733,"median":-52.37212,"eighty":-40.450697,"marketCap":777186134},{"date":"2022-01-14","current":-10.152461,"twenty":-78.808386,"median":-52.330066,"eighty":-40.369456,"marketCap":749241453},{"date":"2022-01-21","current":-8.473189,"twenty":-78.74195,"median":-52.195625,"eighty":-40.147016,"marketCap":625312866},{"date":"2022-01-28","current":-8.341481,"twenty":-78.655834,"median":-51.618626,"eighty":-39.843604,"marketCap":615592977},{"date":"2022-02-04","current":-7.507333,"twenty":-78.517591,"median":-51.204689,"eighty":-39.21928,"marketCap":554033679},{"date":"2022-02-11","current":-8.231725,"twenty":-78.430306,"median":-50.897527,"eighty":-38.45245,"marketCap":607493070},{"date":"2022-02-18","current":-8.231725,"twenty":-78.401772,"median":-50.803651,"eighty":-37.275023,"marketCap":607493070},{"date":"2022-02-25","current":-9.246971,"twenty":-78.298748,"median":-50.561615,"eighty":-36.737247,"marketCap":682417215},{"date":"2022-03-04","current":-8.095702,"twenty":-78.117892,"median":-50.477726,"eighty":-35.075026,"marketCap":675691617},{"date":"2022-03-11","current":-8.825922,"twenty":-77.950932,"median":-50.246862,"eighty":-26.858361,"marketCap":736637945},{"date":"2022-03-18","current":-9.736263,"twenty":-77.842025,"median":-50.16538,"eighty":-24.334226,"marketCap":812617700},{"date":"2022-03-25","current":-8.738296,"twenty":-77.552873,"median":-50.084428,"eighty":-20.659434,"marketCap":729324385},{"date":"2022-04-01","current":-8.850263,"twenty":-77.349566,"median":-49.785034,"eighty":-18.326015,"marketCap":738669489},{"date":"2022-04-08","current":-8.241746,"twenty":-77.221162,"median":-49.531736,"eighty":-17.51711,"marketCap":687880883},{"date":"2022-04-14","current":-7.793878,"twenty":-76.878749,"median":-49.323406,"eighty":-16.89589,"marketCap":650500468},{"date":"2022-04-22","current":-7.018746,"twenty":-76.450733,"median":-49.062508,"eighty":-13.33759,"marketCap":585805636},{"date":"2022-04-29","current":-6.229137,"twenty":-76.041509,"median":-48.76637,"eighty":-12.649417,"marketCap":519902502},{"date":"2022-05-06","current":-5.12271,"twenty":-75.292049,"median":-48.533182,"eighty":-12.244416,"marketCap":427556752},{"date":"2022-05-13","current":-4.189039,"twenty":-74.289836,"median":-48.498423,"eighty":-12.034782,"marketCap":392977948},{"date":"2022-05-20","current":-3.794419,"twenty":-73.182011,"median":-48.249313,"eighty":-11.086487,"marketCap":355958286},{"date":"2022-05-27","current":-3.490866,"twenty":-72.899487,"median":-48.0929,"eighty":-10.458681,"marketCap":327481623},{"date":"2022-06-03","current":-3.295724,"twenty":-72.026844,"median":-47.774966,"eighty":-9.81182,"marketCap":309175197},{"date":"2022-06-10","current":-2.942301,"twenty":-69.838643,"median":-47.421347,"eighty":-9.247467,"marketCap":276020225},{"date":"2022-06-17","current":-2.805702,"twenty":-68.686227,"median":-46.559829,"eighty":-9.18227,"marketCap":263205727},{"date":"2022-06-24","current":-3.469184,"twenty":-67.769149,"median":-46.395038,"eighty":-9.098538,"marketCap":325447576},{"date":"2022-07-01","current":-3.568923,"twenty":-65.99845,"median":-45.687745,"eighty":-8.994531,"marketCap":334804193},{"date":"2022-07-08","current":-4.228067,"twenty":-65.563315,"median":-45.3584,"eighty":-8.846368,"marketCap":396639233},{"date":"2022-07-15","current":-4.492593,"twenty":-65.297717,"median":-45.155297,"eighty":-8.814531,"marketCap":421454610},{"date":"2022-07-22","current":-5.051999,"twenty":-65.11354,"median":-44.961089,"eighty":-8.736349,"marketCap":473933032},{"date":"2022-07-29","current":-4.197712,"twenty":-64.976563,"median":-44.438898,"eighty":-8.619165,"marketCap":393791566},{"date":"2022-08-05","current":-4.973942,"twenty":-64.743307,"median":-44.265338,"eighty":-8.538703,"marketCap":466610462},{"date":"2022-08-12","current":-5.356359,"twenty":-64.073678,"median":-43.907138,"eighty":-8.41026,"marketCap":591647383},{"date":"2022-08-19","current":-5.112888,"twenty":-63.886724,"median":-43.707728,"eighty":-8.340383,"marketCap":564754320},{"date":"2022-08-26","current":-4.887862,"twenty":-63.433892,"median":-43.456619,"eighty":-8.230808,"marketCap":539898611},{"date":"2022-09-02","current":-4.921063,"twenty":-63.086449,"median":-43.183353,"eighty":-8.158015,"marketCap":543565847},{"date":"2022-09-09","current":-4.82515,"twenty":-62.661917,"median":-42.84731,"eighty":-7.986968,"marketCap":532971610},{"date":"2022-09-16","current":-4.493144,"twenty":-61.944008,"median":-42.492549,"eighty":-7.729088,"marketCap":496299251},{"date":"2022-09-23","current":-3.611485,"twenty":-61.460423,"median":-42.033813,"eighty":-7.54782,"marketCap":398913766},{"date":"2022-09-30","current":-3.530328,"twenty":-61.032994,"median":-41.772712,"eighty":-7.202887,"marketCap":389949412},{"date":"2022-10-07","current":-3.692642,"twenty":-60.743489,"median":-41.658236,"eighty":-6.707777,"marketCap":407878120},{"date":"2022-10-14","current":-4.054159,"twenty":-60.626043,"median":-41.588073,"eighty":-6.066342,"marketCap":447810244},{"date":"2022-10-21","current":-4.319764,"twenty":-60.194965,"median":-41.442844,"eighty":-5.374091,"marketCap":477148131},{"date":"2022-10-28","current":-4.61488,"twenty":-59.641614,"median":-41.248337,"eighty":-5.193368,"marketCap":509745783},{"date":"2022-11-04","current":-4.504211,"twenty":-59.348016,"median":-40.938144,"eighty":-5.122179,"marketCap":497521663},{"date":"2022-11-11","current":-4.300453,"twenty":-59.217202,"median":-40.687035,"eighty":-5.030256,"marketCap":521262231},{"date":"2022-11-18","current":-3.537198,"twenty":-59.166887,"median":-40.572559,"eighty":-4.96312,"marketCap":428747355},{"date":"2022-11-25","current":-3.590996,"twenty":-59.119845,"median":-40.463886,"eighty":-4.89524,"marketCap":435268227},{"date":"2022-12-02","current":-3.816274,"twenty":-58.926924,"median":-40.435144,"eighty":-4.797114,"marketCap":462574380},{"date":"2022-12-09","current":-3.614533,"twenty":-58.707207,"median":-40.376841,"eighty":-4.756536,"marketCap":438121109},{"date":"2022-12-16","current":-3.506937,"twenty":-58.527063,"median":-40.251287,"eighty":-4.709417,"marketCap":425079364},{"date":"2022-12-23","current":-3.745664,"twenty":-58.255985,"median":-40.054897,"eighty":-4.634062,"marketCap":454015735},{"date":"2022-12-30","current":-3.789375,"twenty":-58.159166,"median":-39.906151,"eighty":-4.595265,"marketCap":459313944},{"date":"2023-01-06","current":-3.68178,"twenty":-58.138796,"median":-39.727822,"eighty":-4.504211,"marketCap":446272199},{"date":"2023-01-13","current":-3.365718,"twenty":-58.085303,"median":-39.240083,"eighty":-4.478389,"marketCap":407962074},{"date":"2023-01-20","current":-3.036207,"twenty":-57.928357,"median":-39.017899,"eighty":-4.414536,"marketCap":368021731},{"date":"2023-01-27","current":-3.086643,"twenty":-57.857645,"median":-38.302211,"eighty":-4.350751,"marketCap":374135049},{"date":"2023-02-03","current":-2.931974,"twenty":-57.764033,"median":-37.31848,"eighty":-4.296199,"marketCap":355387541},{"date":"2023-02-10","current":-2.747045,"twenty":-57.729011,"median":-37.155517,"eighty":-4.239666,"marketCap":332972042},{"date":"2023-02-17","current":-2.56884,"twenty":-57.621305,"median":-36.70058,"eighty":-4.223535,"marketCap":311371653},{"date":"2023-02-24","current":-2.205705,"twenty":-57.354074,"median":-35.54626,"eighty":-4.200241,"marketCap":267355765},{"date":"2023-03-03","current":-2.192256,"twenty":-57.16858,"median":-33.651476,"eighty":-4.170666,"marketCap":265725547},{"date":"2023-03-10","current":-1.783676,"twenty":-57.122482,"median":-27.791947,"eighty":-4.074467,"marketCap":220251834},{"date":"2023-03-17","current":-1.578503,"twenty":-57.05258,"median":-25.006111,"eighty":-4.025988,"marketCap":194916743},{"date":"2023-03-24","current":-1.542102,"twenty":-56.989742,"median":-23.916278,"eighty":-3.955655,"marketCap":190421808},{"date":"2023-03-31","current":-1.495773,"twenty":-56.654797,"median":-21.770169,"eighty":-3.901832,"marketCap":184700981},{"date":"2023-04-06","current":-1.449443,"twenty":-56.409431,"median":-20.145775,"eighty":-3.885205,"marketCap":178980154},{"date":"2023-04-14","current":-1.638069,"twenty":-56.204581,"median":-19.081139,"eighty":-3.85326,"marketCap":202272092},{"date":"2023-04-21","current":-1.654616,"twenty":-55.946825,"median":-18.126258,"eighty":-3.798897,"marketCap":204315245},{"date":"2023-04-28","current":-1.846551,"twenty":-55.942565,"median":-17.484184,"eighty":-3.767184,"marketCap":228015813},{"date":"2023-05-05","current":-2.101362,"twenty":-55.920558,"median":-17.017719,"eighty":-3.734905,"marketCap":259480361},{"date":"2023-05-12","current":-1.984089,"twenty":-55.832135,"median":-16.422292,"eighty":-3.693832,"marketCap":256211317},{"date":"2023-05-19","current":-1.902097,"twenty":-55.690123,"median":-13.17076,"eighty":-3.654578,"marketCap":245623501},{"date":"2023-05-26","current":-2.060341,"twenty":-55.614879,"median":-12.846979,"eighty":-3.612095,"marketCap":266058068},{"date":"2023-06-01","current":-2.11098,"twenty":-55.421299,"median":-12.572588,"eighty":-3.599066,"marketCap":272597130},{"date":"2023-06-09","current":-2.51292,"twenty":-55.335847,"median":-12.314661,"eighty":-3.56863,"marketCap":324500931},{"date":"2023-06-16","current":-3.025632,"twenty":-55.275002,"median":-12.21588,"eighty":-3.5537,"marketCap":390708930},{"date":"2023-06-23","current":-2.281884,"twenty":-55.245267,"median":-12.034782,"eighty":-3.543223,"marketCap":294666463},{"date":"2023-06-30","current":-2.319862,"twenty":-55.202891,"median":-11.793318,"eighty":-3.523749,"marketCap":299570759},{"date":"2023-07-07","current":-2.003373,"twenty":-55.149894,"median":-11.261,"eighty":-3.507192,"marketCap":258701624},{"date":"2023-07-14","current":-2.250235,"twenty":-55.125388,"median":-10.786303,"eighty":-3.491733,"marketCap":290579549},{"date":"2023-07-21","current":-2.155288,"twenty":-55.099265,"median":-10.410388,"eighty":-3.446634,"marketCap":278318809},{"date":"2023-07-28","current":-1.803986,"twenty":-55.039457,"median":-9.925154,"eighty":-3.375531,"marketCap":232954069},{"date":"2023-08-04","current":-1.788161,"twenty":-54.991977,"median":-9.278658,"eighty":-3.333018,"marketCap":230910612},{"date":"2023-08-11","current":-1.590872,"twenty":-54.964509,"median":-9.227764,"eighty":-3.228425,"marketCap":207405167},{"date":"2023-08-18","current":-1.43936,"twenty":-54.936896,"median":-9.186164,"eighty":-3.186841,"marketCap":187652294},{"date":"2023-08-25","current":-1.417265,"twenty":-54.918358,"median":-9.156556,"eighty":-3.13237,"marketCap":184771667},{"date":"2023-09-01","current":-1.344666,"twenty":-54.835061,"median":-9.069329,"eighty":-3.106144,"marketCap":175306748},{"date":"2023-09-08","current":-1.568777,"twenty":-54.674603,"median":-9.025516,"eighty":-3.086643,"marketCap":204524540},{"date":"2023-09-15","current":-1.581403,"twenty":-54.276021,"median":-8.934523,"eighty":-3.025632,"marketCap":206170613},{"date":"2023-09-22","current":-1.584559,"twenty":-54.256262,"median":-8.83079,"eighty":-2.959169,"marketCap":206582131},{"date":"2023-09-29","current":-1.562464,"twenty":-54.178901,"median":-8.819987,"eighty":-2.922787,"marketCap":203701504},{"date":"2023-10-06","current":-2.439673,"twenty":-54.058325,"median":-8.780507,"eighty":-2.805702,"marketCap":318065046},{"date":"2023-10-13","current":-3.610879,"twenty":-53.947809,"median":-8.733428,"eighty":-2.875086,"marketCap":470757533},{"date":"2023-10-20","current":-2.69383,"twenty":-53.884159,"median":-8.640933,"eighty":-2.875086,"marketCap":351200064},{"date":"2023-10-27","current":-2.644157,"twenty":-53.841288,"median":-8.62136,"eighty":-2.8031,"marketCap":344724035},{"date":"2023-11-03","current":-2.942198,"twenty":-53.664443,"median":-8.578747,"eighty":-2.767568,"marketCap":383580212},{"date":"2023-11-10","current":-2.995692,"twenty":-53.494397,"median":-8.480285,"eighty":-2.780558,"marketCap":390554398},{"date":"2023-11-17","current":-3.046261,"twenty":-53.424971,"median":-8.422523,"eighty":-2.799034,"marketCap":444881991},{"date":"2023-11-24","current":-3.015559,"twenty":-53.318844,"median":-8.370743,"eighty":-2.802233,"marketCap":440398298},{"date":"2023-12-01","current":-2.674433,"twenty":-53.298726,"median":-8.341481,"eighty":-2.802233,"marketCap":390579486},{"date":"2023-12-08","current":-3.155421,"twenty":-53.291293,"median":-8.236735,"eighty":-2.798257,"marketCap":460824011},{"date":"2023-12-15","current":-4.49946,"twenty":-53.270425,"median":-8.227142,"eighty":-2.802233,"marketCap":657110130},{"date":"2023-12-22","current":-4.44488,"twenty":-53.211253,"median":-8.17522,"eighty":-2.810832,"marketCap":649139120},{"date":"2023-12-29","current":-5.21412,"twenty":-53.121754,"median":-8.095702,"eighty":-2.826221,"marketCap":761480541},{"date":"2024-01-05","current":-4.455113,"twenty":-53.072909,"median":-8.065863,"eighty":-2.834762,"marketCap":650633684},{"date":"2024-01-12","current":-4.792829,"twenty":-53.028094,"median":-7.880505,"eighty":-2.853962,"marketCap":699954308},{"date":"2024-01-19","current":-4.352776,"twenty":-52.996307,"median":-7.737821,"eighty":-2.875208,"marketCap":635688041},{"date":"2024-01-26","current":-4.939513,"twenty":-52.96243,"median":-7.643702,"eighty":-2.875697,"marketCap":721376397},{"date":"2024-02-02","current":-5.116899,"twenty":-52.942101,"median":-7.507333,"eighty":-2.879044,"marketCap":747282180},{"date":"2024-02-09","current":-4.71437,"twenty":-52.913137,"median":-7.309163,"eighty":-2.897551,"marketCap":688495981},{"date":"2024-02-16","current":-5.727516,"twenty":-52.83227,"median":-7.018746,"eighty":-2.918978,"marketCap":836457853},{"date":"2024-02-23","current":-5.475082,"twenty":-52.825768,"median":-6.740921,"eighty":-2.922787,"marketCap":799591932},{"date":"2024-03-01","current":-5.004327,"twenty":-52.759205,"median":-6.282752,"eighty":-2.931974,"marketCap":730841972},{"date":"2024-03-08","current":-5.031296,"twenty":-52.638205,"median":-5.931816,"eighty":-2.942198,"marketCap":809057506},{"date":"2024-03-15","current":-3.477477,"twenty":-52.571219,"median":-5.60471,"eighty":-2.942198,"marketCap":559195714},{"date":"2024-03-22","current":-3.901636,"twenty":-52.544424,"median":-5.543307,"eighty":-2.942301,"marketCap":627402545},{"date":"2024-03-28","current":-3.558566,"twenty":-52.53699,"median":-5.410268,"eighty":-2.944036,"marketCap":572235255},{"date":"2024-04-05","current":-3.505546,"twenty":-52.476531,"median":-5.405151,"eighty":-2.956229,"marketCap":563709401},{"date":"2024-04-12","current":-4.172973,"twenty":-52.399301,"median":-5.385913,"eighty":-2.97616,"marketCap":671034857},{"date":"2024-04-19","current":-4.909013,"twenty":-52.365198,"median":-5.336925,"eighty":-2.983672,"marketCap":789393770},{"date":"2024-04-26","current":-5.297814,"twenty":-52.346888,"median":-5.304714,"eighty":-2.990242,"marketCap":851915025},{"date":"2024-05-03","current":-5.219305,"twenty":-52.332746,"median":-5.310685,"eighty":-2.99489,"marketCap":839290321},{"date":"2024-05-10","current":-5.150088,"twenty":-52.226272,"median":-5.297814,"eighty":-2.995826,"marketCap":855954931},{"date":"2024-05-17","current":-4.595538,"twenty":-52.196565,"median":-5.232916,"eighty":-3.00889,"marketCap":763787568},{"date":"2024-05-24","current":-4.604942,"twenty":-51.815379,"median":-5.21412,"eighty":-3.012566,"marketCap":765350571},{"date":"2024-05-31","current":-3.338505,"twenty":-51.667547,"median":-5.190766,"eighty":-3.014404,"marketCap":554866139},{"date":"2024-06-07","current":-2.909044,"twenty":-51.615878,"median":-5.146845,"eighty":-2.995792,"marketCap":483488992},{"date":"2024-06-14","current":-2.645726,"twenty":-51.466242,"median":-5.136333,"eighty":-2.98204,"marketCap":439724903},{"date":"2024-06-21","current":-2.156705,"twenty":-51.24756,"median":-5.124921,"eighty":-2.942735,"marketCap":358448736},{"date":"2024-06-28","current":-1.829124,"twenty":-51.226125,"median":-5.122046,"eighty":-2.942198,"marketCap":304004124},{"date":"2024-07-05","current":-1.755458,"twenty":-51.112175,"median":-5.115194,"eighty":-2.91993,"marketCap":291760599},{"date":"2024-07-12","current":-2.413754,"twenty":-50.94896,"median":-5.106665,"eighty":-2.875697,"marketCap":401170823},{"date":"2024-07-15","current":-2.213131,"twenty":-50.936737,"median":-5.100177,"eighty":-2.875453,"marketCap":367826755},{"date":"2024-08-02","current":-0.877729,"twenty":-50.924515,"median":-5.09369,"eighty":-2.868045,"marketCap":145880299},{"date":"2024-08-09","current":-0.79924,"twenty":-50.888667,"median":-5.045554,"eighty":-2.808126,"marketCap":137023281},{"date":"2024-08-16","current":-0.814154,"twenty":-50.847669,"median":-5.03844,"eighty":-2.78073,"marketCap":139580243},{"date":"2024-08-23","current":-0.715841,"twenty":-50.8107,"median":-5.022591,"eighty":-2.750326,"marketCap":122725270},{"date":"2024-08-30","current":-0.706624,"twenty":-50.765627,"median":-5.014561,"eighty":-2.731986,"marketCap":121145117},{"date":"2024-09-06","current":-0.611384,"twenty":-50.639417,"median":-5.008634,"eighty":-2.70155,"marketCap":104816862},{"date":"2024-09-13","current":-0.657468,"twenty":-50.552022,"median":-4.982615,"eighty":-2.671563,"marketCap":112717630},{"date":"2024-09-20","current":-0.666685,"twenty":-50.529331,"median":-4.955513,"eighty":-2.638883,"marketCap":114297784},{"date":"2024-09-27","current":-0.574516,"twenty":-50.469578,"median":-4.9432,"eighty":-2.606128,"marketCap":98496247},{"date":"2024-10-04","current":-0.528432,"twenty":-50.355504,"median":-4.921063,"eighty":-2.554292,"marketCap":90595478},{"date":"2024-10-11","current":-0.442408,"twenty":-50.26859,"median":-4.913928,"eighty":-2.512424,"marketCap":75847377},{"date":"2024-10-18","current":-0.463914,"twenty":-50.210195,"median":-4.906307,"eighty":-2.409886,"marketCap":79534402},{"date":"2024-10-25","current":-0.447017,"twenty":-50.181677,"median":-4.892548,"eighty":-2.339146,"marketCap":76637454},{"date":"2024-10-31","current":-0.423975,"twenty":-50.168097,"median":-4.886398,"eighty":-2.322394,"marketCap":72687070},{"date":"2024-11-08","current":-0.526164,"twenty":-50.149599,"median":-4.865729,"eighty":-2.305304,"marketCap":79534402},{"date":"2024-11-15","current":-0.46407,"twenty":-50.12155,"median":-4.838881,"eighty":-2.247726,"marketCap":70148328},{"date":"2024-11-22","current":-0.450113,"twenty":-50.071663,"median":-4.823618,"eighty":-2.199653,"marketCap":68038604},{"date":"2024-11-29","current":-0.516409,"twenty":-50.004472,"median":-4.79624,"eighty":-2.184186,"marketCap":78059793},{"date":"2024-12-06","current":-0.631554,"twenty":-49.80139,"median":-4.790545,"eighty":-2.160571,"marketCap":95465018},{"date":"2024-12-13","current":-0.495473,"twenty":-49.741697,"median":-4.772361,"eighty":-2.155288,"marketCap":74895207},{"date":"2024-12-20","current":-0.516409,"twenty":-49.648259,"median":-4.758732,"eighty":-2.143641,"marketCap":78059793},{"date":"2024-12-27","current":-0.589683,"twenty":-49.531736,"median":-4.755235,"eighty":-2.119088,"marketCap":89135845},{"date":"2025-01-03","current":-0.544322,"twenty":-49.365072,"median":-4.734631,"eighty":-2.11038,"marketCap":82279242},{"date":"2025-01-10","current":-0.645511,"twenty":-49.323406,"median":-4.716271,"eighty":-2.105234,"marketCap":97574742},{"date":"2025-01-17","current":-0.568747,"twenty":-49.295225,"median":-4.709417,"eighty":-2.059075,"marketCap":85971259},{"date":"2025-01-24","current":-0.568747,"twenty":-49.211445,"median":-4.702119,"eighty":-2.026574,"marketCap":85971259},{"date":"2025-01-31","current":-0.455347,"twenty":-49.072798,"median":-4.662836,"eighty":-1.999576,"marketCap":68829750},{"date":"2025-02-07","current":-0.41871,"twenty":-48.954024,"median":-4.635911,"eighty":-1.973045,"marketCap":63291724},{"date":"2025-02-14","current":-0.376839,"twenty":-48.827629,"median":-4.611191,"eighty":-1.937255,"marketCap":56962552},{"date":"2025-02-21","current":-0.390796,"twenty":-48.758329,"median":-4.605142,"eighty":-1.903623,"marketCap":59072276},{"date":"2025-02-28","current":-0.373349,"twenty":-48.694013,"median":-4.592746,"eighty":-1.878159,"marketCap":56435121},{"date":"2025-03-07","current":-0.5186,"twenty":-48.552519,"median":-4.548923,"eighty":-1.854624,"marketCap":69933229},{"date":"2025-03-14","current":-0.329133,"twenty":-48.500449,"median":-4.536984,"eighty":-1.818642,"marketCap":44383578},{"date":"2025-03-21","current":-0.296315,"twenty":-48.498423,"median":-4.501836,"eighty":-1.784573,"marketCap":39958032},{"date":"2025-03-28","current":-0.282736,"twenty":-48.485026,"median":-4.493144,"eighty":-1.755458,"marketCap":38126956},{"date":"2025-04-04","current":-0.211043,"twenty":-48.399336,"median":-4.483808,"eighty":-1.66538,"marketCap":28459087},{"date":"2025-04-11","current":-0.190021,"twenty":-48.262288,"median":-4.467322,"eighty":-1.643364,"marketCap":25624389},{"date":"2025-04-17","current":-0.221692,"twenty":-48.227689,"median":-4.454474,"eighty":-1.635063,"marketCap":29895121},{"date":"2025-04-25","current":-0.237923,"twenty":-48.209827,"median":-4.430186,"eighty":-1.611596,"marketCap":32083871}],"updateTime":1745884766121}}}